维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Edvardsson U"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A proteome analysis of livers from obese(ob/ob) mice treated with the peroxisome proliferator WY14,643显示文摘	Edvardsson U Alexandersson M Brockenhuus VL	1999	Electrophoresis1999，20，45：	1
2	Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators 显示文摘	Edvardsson U yon Lowenhielm HB Panfilov O	2003	Proteomics2003，3，4：	1
3	Rosiglitazone (BRL49653),aPPARgamma-selective agonist causes peroxisome proliferator-like liver effects in obese mice显示文摘	Edvardsson U Bergstrom M Alexandersson M	1999	J Lipid Res1999，40，7：	1
4	Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisomeprol ferator-activated receptor activators显示文摘	Edvardsson U Brockenhuus VLH Panfilov O	2003	Proteomics2003，3，：	1
5	He- patic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor acti- vators 显示文摘	Edvardsson U von Lowenhielm HB Panfilov O	2003	Proteomics2003，3，4：	1
6	Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators显示文摘	Edvardsson U yon Lowenhielm HB Panfilov O	2003	Proteomics2003，3，4：	1
7	Insulin and oleic acid increase PPARgamma2 expression in cultured mouse hepatocytes 显示文摘	Edvardsson U Ljungberg A Oscarsson j	2006	Biochem Biophys Res Commun2006，340，：	1
8	PPARa activation increases triglyceride mass and adipose differentiation-related protein in hepatytes显示文摘	Edvardsson U	2006	Journal of Lipid Research2006，47，：	1
9	Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferatorslike liver effects in obese mice 显示文摘	Edvardsson U Bergstrom M Alexandersson M Bamberg K Ljung B Dahllof B	1999	J Lipid Res1999，40，：	1
10	PPARa activation increases triglyceride mass and adipose dii}erentiation-related protein in hepatocytes显示文摘	Edvardsson U	2006	Journal of lipid research2006，47，2：	1
11	Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery 显示文摘	Edvardsson N Berggren H	1993	Thorac Cardiovasc Surg1993，41，1：	1
12	Proteome analysis of liver from obseas (ob/bo) mice treated with the peroxisome proliferators显示文摘	Edvardsson U Bruckenhum A M von Lowenhielm H	1999	Elecvnphoresix1999，20，45：	1
13	Oral sotaol reduces the incidence of atrial fibrillation after coronary artery bypass surgery显示文摘	Nystrom U Shandling A H Edvardsson N	1993	J Thorac Cardiovasc Surg1993，41，1：	1
14	Drivers of Cus- tomers' Service Experiences:A Study in The Restau- rant Industry显示文摘	Walter U Edvardsson B Ostrom A	2010	Managing Service Quality2010，20，3：	1
15	Hepatic protein expression of lean mice and obese diabet-ic mice treated with peroxisome proliferator - activated recep-tor activators显示文摘	EDVARDSSON U von LOWENHIELM HB PANFILOV 〇 etal	2003	Proteomics2003，3，4：	1
16	Rosiglitazone ( BRL49653 ), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice 显示文摘	EDVARDSSON U BERGSTROM M ALEXANDERSSON M	1999	J Lipid Res1999，40，7：	1
17	A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643显示文摘	Edvardsson U Alexandersson M Brockenhuus von Lowenhielm H	1999	Electrophoresis1999，20，45：	1
18	Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferater-activated receptor activators显示文摘	Edvardsson U Von Lowenhiehn HB Panfdov O	2003	Proteomics2003，3，4：	1
19	A proteome analysis of liver from obsess (ob/bo) mice treated with the peroxisome proliferaturs WY14643显示文摘	Edvardsson U Alexanderson M Brockenhuus yon Lowenhielm H	1999	Electrophoresis1999，20，45：	1
20	Rosiglitazone(BRIA9653),A Pargamma-selective Agonist,Causes Peroxisome Proliferators-like Liver Efects in Obese Mice显示文摘	EDVARDSSON U BERGSTROM M MEXANDERSSON M	1999	J Lipid Res(S0022-2275)1999，40，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示